CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency

Although inhibitors targeting tumor angiogenic pathway have provided improvement for clinical treatment in patients with various solid tumors, the still very limited anti‐cancer efficacy and acquired drug resistance demand new agents that may offer better clinical benefits. In the effort to find a s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Zhou, You, Shan, Song, Li, Zhi‐Bin, Xin, Li‐Jun, Pan, De‐Si, Yang, Qian‐Jiao, Liu, Ying‐Ping, Yue, Xu‐Peng, Liu, Xiao‐Rong, Gao, Ji‐Zhou, Zhang, Jin‐Wen, Ning, Zhi‐Qiang, Lu, Xian‐Ping
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378272/
https://ncbi.nlm.nih.gov/pubmed/28004478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13141
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados